Müller, Britta
Dresler, Thomas
Gaul, Charly
Jürgens, Tim
Kropp, Peter
Rehfeld, Anna
Reis, Olaf
Ruscheweyh, Ruth
Straube, Andreas
Förderreuther, Stefanie
Funding for this research was provided by:
German Migraine and Headache Society (DMKG e.V., http://dmkg.de/). (N/A)
Article History
Received: 29 November 2019
Accepted: 19 March 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: The Ethics Committee of the Faculty of Medicine, University of Leipzig reviewed and approved the study (297/16-ek). All participants gave their written informed consent.
: Not applicable
: TD has received honoraria for consulting and lectures within the past 3 years from Hormosan Pharma, Novartis Pharma, and TEVA. CG has received honoraria for consulting and lectures within the past 3 years from Allergan Pharma, Bayer vital, Boehringer Ingelheim Pharma, Cerbotec, Desitin Arzneimittel, electroCore, Grünenthal, Hormosan Pharma, Lilly Germany, Novartis Pharma, Ratiopharm, Reckitt Benckiser, Sanofi Aventis, and TEVA. TJ has received honoraria for consulting and lectures from Allergan Pharma, Autonomic Technologies, Desitin Arzneimittel, Lilly Germany, Novartis Pharma, and TEVA. PK has received honoraria for consulting and lectures from Novartis Pharma and Shire. RR has received honoraria for consulting and lectures within the past 3 years from Allergan Pharma, Hormosan Pharma, Novartis Pharma, Lilly Germany, and TEVA. AS has received honoraria for consulting and educational lectures from Allergan Pharma, Bayer, Desitin Arzneimittel, electroCore, Lilly Germany, Novartis Pharma, Sanofi Aventis, and TEVA. SF has received honoraria for consulting and lectures within the past three years from Allergan Pharma, Astra Zeneca, Hormosan Pharma, Lilly Germany, Novartis Pharma, Sanofi Aventis, and TEVA.